KLH2301 Investigators

No ORCID on file · 1 paper in corpus

rct 2026

Linzagolix versus leuprorelin in Japanese women with uterine leiomyomas: a phase 3, randomized, active-controlled, non-inferiority trial

Human reproduction (Oxford, England) ·doi:10.1093/humrep/deag106

STUDY QUESTION: How does the efficacy of linzagolix (a gonadotropin-releasing hormone [GnRH] receptor antagonist) compare with leuprorelin (a GnRH agonist) for the treatment of heavy menstrual bleeding (HMB) in patients with uterine leiomyo…